These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36100654)

  • 21. In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model.
    Choi H; Kim YK; Oh SW; Im HJ; Hwang DW; Kang H; Lee B; Lee YS; Jeong JM; Kim EE; Chung JK; Lee DS
    PLoS One; 2014; 9(3):e92765. PubMed ID: 24663806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain.
    Elmenhorst D; Mertens K; Kroll T; Oskamp A; Ermert J; Elmenhorst EM; Wedekind F; Beer S; Coenen HH; Bauer A
    J Sleep Res; 2016 Dec; 25(6):754-761. PubMed ID: 27357735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients.
    Ceccarini J; Leurquin-Sterk G; Crunelle CL; de Laat B; Bormans G; Peuskens H; Van Laere K
    J Nucl Med; 2020 Feb; 61(2):256-262. PubMed ID: 31481578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease.
    Kang Y; Henchcliffe C; Verma A; Vallabhajosula S; He B; Kothari PJ; Pryor KO; Mozley PD
    J Neuroimaging; 2019 Jan; 29(1):97-103. PubMed ID: 30230118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans.
    Park E; Sullivan JM; Planeta B; Gallezot JD; Lim K; Lin SF; Ropchan J; McCarthy TJ; Ding YS; Morris ED; Williams WA; Huang Y; Carson RE
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1530-41. PubMed ID: 26044120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
    Wyckhuys T; Verhaeghe J; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
    J Nucl Med; 2013 Nov; 54(11):1954-61. PubMed ID: 24050937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats.
    de Laat B; Weerasekera A; Leurquin-Sterk G; Bormans G; Himmelreich U; Casteels C; Van Laere K
    J Nucl Med; 2018 Jun; 59(6):952-959. PubMed ID: 29496988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic Changes in Striatal mGluR1 But Not mGluR5 during Pathological Progression of Parkinson's Disease in Human Alpha-Synuclein A53T Transgenic Rats: A Multi-PET Imaging Study.
    Yamasaki T; Fujinaga M; Kawamura K; Furutsuka K; Nengaki N; Shimoda Y; Shiomi S; Takei M; Hashimoto H; Yui J; Wakizaka H; Hatori A; Xie L; Kumata K; Zhang MR
    J Neurosci; 2016 Jan; 36(2):375-84. PubMed ID: 26758830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of the metabotropic glutamate receptor 5 (mGluR5) PET tracer [(18)F]FPEB for human use: An automated radiosynthesis and a novel one-pot synthesis of its radiolabeling precursor.
    Lim K; Labaree D; Li S; Huang Y
    Appl Radiat Isot; 2014 Dec; 94():349-354. PubMed ID: 25305528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry.
    Wong DF; Waterhouse R; Kuwabara H; Kim J; Brašić JR; Chamroonrat W; Stabins M; Holt DP; Dannals RF; Hamill TG; Mozley PD
    J Nucl Med; 2013 Mar; 54(3):388-96. PubMed ID: 23404089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.
    Milella MS; Marengo L; Larcher K; Fotros A; Dagher A; Rosa-Neto P; Benkelfat C; Leyton M
    Neuroimage; 2014 Sep; 98():195-202. PubMed ID: 24795154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging.
    DuBois JM; Rousset OG; Guiot MC; Hall JA; Reader AJ; Soucy JP; Rosa-Neto P; Kobayashi E
    Cereb Cortex; 2016 Oct; 26(11):4170-4179. PubMed ID: 27578494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study.
    Leurquin-Sterk G; Ceccarini J; Crunelle CL; Weerasekera A; de Laat B; Himmelreich U; Bormans G; Van Laere K
    Addict Biol; 2018 May; 23(3):931-944. PubMed ID: 28884874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression.
    Kim JH; Joo YH; Son YD; Kim JH; Kim YK; Kim HK; Lee SY; Ido T
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):278-290. PubMed ID: 30553696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test-retest variability of [
    Smart K; Cox SML; Nagano-Saito A; Rosa-Neto P; Leyton M; Benkelfat C
    Synapse; 2018 Sep; 72(9):e22041. PubMed ID: 29935121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [
    Kim SE; Joo YH; Son YD; Kim HK; Lee SY; Lee MW; Ido T; Kim JH
    Brain Struct Funct; 2020 Jul; 225(6):1805-1816. PubMed ID: 32495131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.
    Davis MT; Hillmer A; Holmes SE; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Angarita GA; Carson RE; Krystal JH; Esterlis I
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11490-11495. PubMed ID: 31085640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in [
    Smart K; Cox SML; Scala SG; Tippler M; Jaworska N; Boivin M; Séguin JR; Benkelfat C; Leyton M
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1179-1183. PubMed ID: 30627817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans.
    Sullivan JM; Lim K; Labaree D; Lin SF; McCarthy TJ; Seibyl JP; Tamagnan G; Huang Y; Carson RE; Ding YS; Morris ED
    J Cereb Blood Flow Metab; 2013 Apr; 33(4):532-41. PubMed ID: 23250105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.